Algo version: 0.98b
Aarey Drugs & is listed at the NSE Exchange
Aarey Drugs & [AAREYDRUGS.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Aarey Drugs & stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Aarey Drugs & pays dividends. Last time was Sunday 30th of December 2018 where the investors holding the stock on Thursday 13th of December 2018 were paid INR0.1 per share. Over the last 1 times between 2018 and 2018, Aarey Drugs & has paid INR0.1 with an average of INR0.1 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Aarey Drugs & 10 years ago, but if you had invested on Friday 6th of August 2021 when the price was INR43.35, you would have made a profit of INR27.34 per share or 63.07%

Yes, the average daily trading liquidity for Aarey Drugs & is INR142 273 thousand. You should therefore be able to get in and out of your positions relatively fast.

Aarey Drugs & has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.10, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 1.41%, which is challenging.

We have calculated the inflation risk for Aarey Drugs & to be medium [0.65 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.